Hepatic transporter‐mediated pharmacokinetic drug–drug interactions: Recent studies and regulatory recommendations
- 28 January 2021
- journal article
- review article
- Published by Wiley in Biopharmaceutics & Drug Disposition
- Vol. 42 (2-3) , 45-77
Abstract
Transporter‐mediated drug‐drug interactions are one of the major mechanisms in pharmacokinetic based drug interactions and correspondingly affecting drugs’ safety and efficacy. Regulatory bodies underlined the importance of the evaluation of transporter‐mediated interactions as a part of the drug development process. The liver is responsible for the elimination of a wide range of endogenous and exogenous compounds via metabolism and biliary excretion. Therefore, hepatic uptake transporters, expressed on the sinusoidal membranes of hepatocytes, and efflux transporters mediating the transport from hepatocytes to the bile are determinant factors for pharmacokinetics of drugs, and hence, drug‐drug interactions. In parallel with the growing research interest in this area, regulatory guidances have been updated with detailed assay models and criteria. According to well‐established preclinical results, observed or expected hepatic transporter‐mediated drug‐drug interactions can be taken into account for clinical studies. In this paper, various methods including in vitro, in situ, in vivo, in silico approaches, and combinational concepts and several clinical studies on the assessment of transporter‐mediated drug‐drug interactions were reviewed. Informative and effective evaluation by preclinical tools together with the integration of pharmacokinetic modeling and simulation can reduce unexpected clinical outcomes and enhance the success rate in drug development.Keywords
This publication has 173 references indexed in Scilit:
- Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADMEArchives of Toxicology, 2013
- Species differences in drug transporters and implications for translating preclinical findings to humansExpert Opinion on Drug Metabolism & Toxicology, 2012
- Absolute abundance and function of intestinal drug transporters: a prerequisite for fully mechanisticin vitro–in vivoextrapolation of oral drug absorptionBiopharmaceutics & Drug Disposition, 2012
- Use of Mechanistic Modeling to Assess Interindividual Variability and Interspecies Differences in Active Uptake in Human and Rat HepatocytesDrug Metabolism and Disposition, 2012
- Simultaneous Assessment of Uptake and Metabolism in Rat Hepatocytes: A Comprehensive Mechanistic ModelThe Journal of Pharmacology and Experimental Therapeutics, 2012
- Screening of OATP1B1/3 and OCT1 inhibitors in cryopreserved hepatocytes in suspensionEuropean Journal of Pharmaceutical Sciences, 2010
- Membrane transporters in drug developmentNature Reviews Drug Discovery, 2010
- Relationship between Drug/Metabolite Exposure and Impairment of Excretory Transport FunctionDrug Metabolism and Disposition, 2009
- Expression and hepatobiliary transport characteristics of the concentrative and equilibrative nucleoside transporters in sandwich-cultured human hepatocytesAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2008
- Kinetic analysis of albumin-mediated uptake of warfarin by perfused rat liverJournal of Pharmacokinetics and Biopharmaceutics, 1988